New Rules on Centralised Authorisation for Device Trials in Germany Continue to Frustrate Industry
This article was originally published in RAJ Devices
Executive Summary
Medical technology firms in Germany see recent regulatory and political changes in their country as largely positive, with one or two exceptions. Tobias Weiler, head of the medical technology department of industry association Spectaris, tells Ashley Yeo about his hopes and fears for the industry.